
MD, PhD
Consultant medical oncologist offering chemotherapy, targeted therapy, and immunotherapy for cancer care
Experience
—
Languages
Arabic, English
Location
Dubai, Sharjah
Sees
adults, seniors
Dr. Moustafa Al Daly is a Consultant in Medical Oncology at Aster Hospital, Sharjah, with an MD and PhD in Clinical Oncology from Cairo University. He specializes in diagnosing and treating various types of cancer using evidence-based approaches tailored to each patient's individual needs.
His clinical expertise spans cancer diagnosis, chemotherapy, targeted therapy (drugs designed to attack specific cancer cells), immunotherapy (helping the body's immune system fight cancer), and supportive care to manage side effects. Dr. Al Daly brings advanced training in both cancer research and clinical practice, enabling him to manage complex cases with precision and care.
Fluent in English and Arabic, Dr. Al Daly is committed to serving a diverse patient community with compassion. He is known for a patient-centered approach that prioritizes understanding each person's needs and concerns throughout their cancer treatment journey.
Special interests: patient-centered oncology care, evidence-based cancer therapy, supportive cancer care.
Extracted from the doctor's hospital profile — patient-friendly terms
MD and PhD in Clinical Oncology
Cairo University, Egypt
Consultant in Medical Oncology
Aster Hospital, Sharjah, United Arab Emirates
Consultations are available in Arabic, English.
Aster Hospitals — Aster Hospital, Sharjah, Dubai, Sharjah.
This doctor primarily sees adults and seniors.
Profile compiled from Aster Hospitals's public website (see original profile via the booking link). Data is informational, not medical advice.
Aster Hospital Sharjah: 4.7★ · 6,758 Google reviews — Google rating for the clinic, not this doctor.
No patient reviews yet — be the first.
Visited Dr. Daly? Your experience helps others choose with confidence.
Write the first reviewReviews are written by signed-in users who attest to a visit, screened before publication, and labeled “Patient-reported” until visit verification launches. They are opinions, not medical advice.